Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Trastuzumab > Ado-Trastuzumab Emtansine
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Trastuzumab > Ado-Trastuzumab Emtansine
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Trastuzumab > Ado-Trastuzumab Emtansine
... > Organic Chemicals > Lactones > Polyketides > Macrolides > Maytansine > Ado-Trastuzumab Emtansine
... > Polycyclic Compounds > Macrocyclic Compounds > Polyketides > Macrolides > Maytansine > Ado-Trastuzumab Emtansine
Polycyclic Compounds > Macrocyclic Compounds > Lactams, Macrocyclic > Maytansine > Ado-Trastuzumab Emtansine
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Lactams > Lactams, Macrocyclic > Maytansine > Ado-Trastuzumab Emtansine
... > Organic Chemicals > Amides > Lactams > Lactams, Macrocyclic > Maytansine > Ado-Trastuzumab Emtansine

Preferred term

Ado-Trastuzumab Emtansine  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Trastuzumab Emtansine

Scope note

  • Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.

History note

  • 2020 (2010)

In other languages

URI

http://www.yso.fi/onto/mesh/D000080044

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/8/19, last modified 1/16/19